Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects
Scaggiante, Bruna, Farra, Rosella, Dapas, Barbara, Baj, Gabriele, Pozzato, Gabriele, Grassi, Mario, Zanconati, Fabrizio, Grassi, GabrieleVolume:
506
Language:
english
Journal:
International Journal of Pharmaceutics
DOI:
10.1016/j.ijpharm.2016.04.031
Date:
June, 2016
File:
PDF, 1.20 MB
english, 2016